Financial Comparison: Sol-Gel Technologies (NASDAQ:SLGL) & Xebra Brands (OTCMKTS:XBRAF)

Xebra Brands (OTCMKTS:XBRAF) and Sol-Gel Technologies (NASDAQ:SLGL) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership and earnings.

Institutional & Insider Ownership

26.2% of Sol-Gel Technologies shares are owned by institutional investors. 66.5% of Sol-Gel Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Xebra Brands and Sol-Gel Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Xebra Brands	0	0	0	0	0.00
Sol-Gel Technologies	1	1	3	1	2.67

Sol-Gel Technologies has a consensus price target of $197.50, suggesting a potential upside of 153.47%. Given Sol-Gel Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe Sol-Gel Technologies is more favorable than Xebra Brands.

Earnings & Valuation

This table compares Xebra Brands and Sol-Gel Technologies”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Xebra Brands	N/A	N/A	N/A	N/A	N/A
Sol-Gel Technologies	$19.39 million	11.29	-$6.13 million	($0.34)	-229.18

Xebra Brands has higher earnings, but lower revenue than Sol-Gel Technologies.

Profitability

This table compares Xebra Brands and Sol-Gel Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Xebra Brands	N/A	N/A	N/A
Sol-Gel Technologies	-5.66%	-3.17%	-2.58%

Summary

Sol-Gel Technologies beats Xebra Brands on 7 of the 10 factors compared between the two stocks.

About Xebra Brands

Xebra Brands Ltd. engages in the cultivation, processing, manufacturing, design, and delivery of cannabis products in Canada and Mexico. It provides cannabis infused beverages, including seltzers, soft drinks, iced teas, lemonades, waters, and energy and sport drinks; and wellness products that include capsules, tinctures, topicals, and intimate oils for personal care. The company offers its products under the HighJack, MadCap, Vicious Citrus, Conquer, HolaHi, and HighCastle brands. Xebra Brands Ltd. was incorporated in 2019 and is headquartered in Vancouver, Canada.

About Sol-Gel Technologies

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.